BRIEF published on 09/02/2024 at 14:32, 2 months 20 days ago Funding Circle Plc: TVR-Total Voting Rights Voting Rights Shares Compliance Transparency Funding Circle
PRESS RELEASE published on 09/02/2024 at 14:27, 2 months 20 days ago Funding Circle Plc: TVR-Total Voting Rights Funding Circle Plc announces total voting rights as at 30 August 2024. Share capital consists of 339,417,634 ordinary shares with voting rights Share Capital Disclosure And Transparency Rules Total Voting Rights Funding Circle Plc Financial Conduct Authority
BRIEF published on 08/30/2024 at 18:03, 2 months 23 days ago Funding Circle Plc Executes Share Buyback Transaction London Stock Exchange Ordinary Shares Share Buyback Funding Circle Share Capital Adjustment
PRESS RELEASE published on 08/30/2024 at 17:58, 2 months 23 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Plc announces purchase and cancellation of 103,634 ordinary shares on the London Stock Exchange as part of buy-back scheme London Stock Exchange Ordinary Shares Purchase Cancellation Funding Circle Plc
BRIEF published on 08/29/2024 at 17:56, 2 months 24 days ago Funding Circle Plc: POS-Transaction in Own Shares Share Buy-back Transparency Rules Numis Securities Funding Circle Stock Cancellation
PRESS RELEASE published on 08/29/2024 at 17:51, 2 months 24 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Plc announced the purchase and cancellation of 200,000 ordinary shares on the London Stock Exchange, as part of its buy-back program London Stock Exchange Ordinary Shares Share Buyback Cancellation Funding Circle Plc
BRIEF published on 08/28/2024 at 18:41, 2 months 25 days ago Funding Circle Plc: POS-Transaction in Own Shares Share Buy-back London Stock Exchange Ordinary Shares Funding Circle Plc Numis Securities
PRESS RELEASE published on 08/28/2024 at 18:36, 2 months 25 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Plc announces the purchase and cancellation of 186,126 ordinary shares at prices ranging from 103.50p to 105.00p per share on the London Stock Exchange London Stock Exchange Buy-back Program Share Purchase Cancellation Funding Circle Plc
BRIEF published on 08/27/2024 at 18:44, 2 months 26 days ago Funding Circle Plc: Share Buyback and Cancellation London Stock Exchange Share Buyback Market Abuse Regulation Capital Reduction Funding Circle
PRESS RELEASE published on 08/27/2024 at 18:39, 2 months 26 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Plc announces buy-back of 210,892 ordinary shares at prices ranging from 102.00p to 105.00p. Company's share capital to consist of 339,417,634 shares after cancellation Share Capital London Stock Exchange Ordinary Shares Funding Circle Plc Buy-back
Published on 11/22/2024 at 23:55, 4 hours 48 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 5 hours 13 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 5 hours 38 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 6 hours 13 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 10 hours 29 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 10 hours 50 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 11 hours 48 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 12 hours 43 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 1 day 21 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 9 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 10 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 10 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
